AI-GPE Lab中文
DatasetsSage Bionetworks

BrainSeq - Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

Abstract

This ambitious project seeks to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmaceutical companies and a not-for-profit medical research institution working as a precompetitive team to generate and analyze publicly available archival

Catalogue metadata

Record ID
AISLI-R-95352844F6B39BE4D0C8
Type
Datasets
Source catalogue
registry.opendata.aws
الموضوع
生命科学与生物医学
شروط الاستخدام
CC BY